½ÃÀ庸°í¼­
»óǰÄÚµå
1708191

¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)

Blood Ketone Meters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº 2024³â 4¾ï 1,510¸¸ ´Þ·¯ ±Ô¸ð·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 7.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, ´ë»ç °Ç°­ ¸ð´ÏÅ͸µÀÇ Ã¤Å÷ü Áõ°¡, ÄÉÅäÁ¦´Ð ´ÙÀÌ¾îÆ®¿Í Àúź¼öÈ­¹° ´ÙÀÌ¾îÆ®ÀÇ Àα⠱޻ó½Â¿¡ ±âÀÎÇÕ´Ï´Ù. ´õ ¸¹Àº »ç¶÷µéÀÌ °Ç°­¿¡ °ü½ÉÀ» °®°í °³ÀÎ ¸ÂÃãÇü °Ç°­ °ü¸® ¼Ö·ç¼ÇÀ» Ãß±¸ÇÔ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áý¿¡¼­ °£ÆíÇÏ°Ô ÄÉÅæ ³óµµ¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ÇöÀå °Ë»ç(Point-of-Care)´Â ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ¼ÒºñÀÚµéÀÌ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ½±°Ô ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÇ¸é¼­ ½ÃÀå ħÅõ°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÄÉÅæ ½Ä´ÜÀ̳ª Àúź¼öÈ­¹° ½Ä´ÜÀÌ Ã¼Áß °ü¸®, ´ç´¢º´ °ü¸®, ½ÅÁø´ë»ç °³¼± µî¿¡ »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÄÉÅæ ¸ð´ÏÅ͸µÀº ÀÌ·¯ÇÑ ½Ä´Ü¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, °³ÀÎÀÌ ¿¡³ÊÁö ¼öÁØÀ» Æò°¡ÇÏ°í ¿µ¾ç °èȹÀ» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÚ°¡ ¸ð´ÏÅ͸µ Ãß¼¼´Â °³ÀÎÈ­µÈ ÇコÄÉ¾î ¼Ö·ç¼Ç ¹× ¿¹¹æÀû °Ç°­ °ü¸®·ÎÀÇ ±¤¹üÀ§ÇÑ Àüȯ°ú ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Blood Ketone Meters Market-IMG1

Ç÷Áß ÄÉÅæ ÃøÁ¤±â´Â Ç÷Áß ÄÉÅæ ¸ð´ÏÅ͸µ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ, ¼Ò¸ðǰ µî Á¦Ç° À¯Çüº°·Î ±¸ºÐµË´Ï´Ù. Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ ºÐ¾ß´Â ÇÑ ¹øÀÇ °Ë»ç·Î Æ÷µµ´ç°ú ÄÉÅæÀ» ¸ðµÎ ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ´Ù±â´É ±â±âÀÇ °³¹ß·Î 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.4%ÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº º¸´Ù È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °Ë»ç¸¦ Á¦°øÇÔÀ¸·Î½á ƯÈ÷ ´ç´¢º´À» °ü¸®ÇÏ´Â »ç¿ëÀÚµéÀÇ ¸ð´ÏÅ͸µ °úÁ¤À» °£¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ½Ç½Ã°£ ÅëÂû·ÂÀ» Á¦°øÇÔÀ¸·Î½á 1Çü ´ç´¢º´ ȯÀÚÀÇ »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â ´ç´¢º´¼º ÄÉÅæ»êÁõ(DKA)À» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÅëÇÕ ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áúº´ °ü¸®¸¦ °£¼ÒÈ­Çϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 4¾ï 1,510¸¸ ´Þ·¯
¿¹»ó ±Ý¾× 8¾ï 1,830¸¸ ´Þ·¯
CAGR 7.2%

¿ëµµ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â´Â ´ç´¢º´ °ü¸®, üÁß ¹× ½Ä´Ü °ü¸®, ½ºÆ÷Ã÷ °æ±â·Â ¸ð´ÏÅ͸µ, °£Áú Ä¡·á ¹× ±âŸ °Ç°­ °ü·Ã ¸ñÀûÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´ °ü¸® ºÐ¾ß¿¡¼­¸¸ 2024³â 1¾ï 7,600¸¸ ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇß°í, ÀÌ´Â DKA¸¦ ¿¹¹æÇϱâ À§ÇØ ÄÉÅæ ³óµµ¸¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÏ´Ù´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ Æ¯È÷ À§Çè¿¡ óÇÑ È¯ÀÚµéÀ» À§ÇÑ Á¤±âÀûÀÎ ÄÉÅæ ¸ð´ÏÅ͸µÀÇ Á߿伺À» °­Á¶ÇÔ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á¿Í ´õ ³ªÀº Áúº´ °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀº Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº 2024³â 1¾ï 5,240¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇßÀ¸¸ç, ¹Ì±¹ ³» ´ç´¢º´ ¹× ´ë»ç¼º ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ¼¼°è ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. üÁß °¨·®°ú ½ÅÁø´ë»ç °Ç°­ ÁõÁøÀ» À§ÇÑ ÄÉÅæ ´ÙÀÌ¾îÆ®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µÀÌ °áÇÕµÈ ÅëÇÕ ±â±â¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÷´Ü ´Ù±â´É ÇコÄÉ¾î ¼Ö·ç¼ÇÀ¸·ÎÀÇ ±¤¹üÀ§ÇÑ ÀüȯÀ» ¹Ý¿µÇÏ¿© ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °³ÀÎÈ­µÈ °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹Ì±¹ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • ±â¼úÀû Àü¸Á
  • °¡°Ý ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • °¸ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ - °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ãß»ê ¹× ¿¹Ãø : Á¦Ç°º°, 2021³â-2034³â

  • ÁÖ¿ä µ¿Çâ
  • Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ
  • Ç÷Áß ÄÉÅæ ¸ð´ÏÅ͸µ
  • ¼Ò¸ðǰ

Á¦6Àå ½ÃÀå Ãß»ê ¹× ¿¹Ãø : ¿ëµµº°, 2021³â-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ´ç´¢º´ °ü¸®
  • üÁß ¹× ½Ä»ç °ü¸®
  • ½ºÆ÷Ã÷ ¸ð´ÏÅ͸µ
  • °£Áú Ä¡·á
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ãß»ê ¹× ¿¹Ãø : À¯Åë ä³Îº°, 2021³â-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ¿ÀÇÁ¶óÀÎ ¸ÅÀå
  • E-Commerce

Á¦8Àå ½ÃÀå Ãß»ê ¹× ¿¹Ãø : Áö¿ªº°, 2021³â-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • A. Menarini Diagnostics
  • Abbott
  • ACON
  • eBmonitor
  • EKF Diagnostics
  • e-LinkCare
  • Fora
  • IN4 Care
  • i-Sens
  • KetoBM
  • KETO-MOJO
  • Ketoscan
  • Lepu Medical
  • TaiDoc
  • VIVOO
LSH 25.05.14

The Global Blood Ketone Meters Market generated USD 415.1 million in 2024 and is projected to grow at a CAGR of 7.2% between 2025 and 2034. This growth is driven by the increasing prevalence of diabetes, rising adoption of metabolic health monitoring, and the surging popularity of ketogenic and low-carbohydrate diets. As more individuals become health-conscious and seek personalized health management solutions, the demand for blood ketone meters continues to rise. Point-of-care testing, which allows individuals to monitor their ketone levels conveniently at home, has further contributed to market expansion. These advancements make it easier for consumers to track their health, leading to greater market penetration. Additionally, the growing awareness of the benefits of ketogenic and low-carb diets, often used for weight management, diabetes control, and improving metabolic health, is propelling demand. Ketone monitoring is becoming an integral part of these diets, enabling individuals to assess their energy levels and ensure that their nutritional plans remain safe and effective. This trend toward self-monitoring aligns with the broader shift toward personalized healthcare solutions and preventive health management, further bolstering market growth.

Blood Ketone Meters Market - IMG1

Blood ketone meters are segmented by product type, including blood ketone monitoring, blood glucose and ketone monitoring, and consumables. The blood glucose and ketone monitoring segment is expected to grow at a CAGR of 7.4% between 2025 and 2034, driven by the development of multifunctional devices capable of measuring both glucose and ketone levels in a single test. These innovations simplify the monitoring process for users, especially those managing diabetes, by offering more efficient and reliable testing. By providing real-time insights, these devices help prevent diabetic ketoacidosis (DKA), a potentially life-threatening condition for individuals with type 1 diabetes. As technology advances, the growing adoption of integrated monitoring devices is streamlining disease management and enhancing patient outcomes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$415.1 Million
Forecast Value$818.3 Million
CAGR7.2%

In terms of application, blood ketone meters are widely used for diabetes management, weight and diet control, sports performance monitoring, epilepsy treatment, and other health-related purposes. The diabetes management segment alone generated USD 176 million in 2024, reflecting the critical need for monitoring ketone levels to prevent DKA. As healthcare providers emphasize the importance of regular ketone monitoring, particularly for at-risk patients, the demand for blood ketone meters continues to increase. With a growing focus on preventive care and better disease management, the adoption of these devices is expected to remain strong.

The U.S. blood ketone meters market generated USD 152.4 million in 2024, leading the global market due to the high prevalence of diabetes and metabolic disorders in the country. The growing interest in ketogenic diets for weight loss and improved metabolic health further supports market growth. Additionally, the increasing preference for integrated devices that combine blood glucose and ketone monitoring is driving demand, reflecting a broader shift toward advanced, multifunctional healthcare solutions. As awareness of personalized health management rises, the U.S. market is expected to witness continued growth in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing adoption of the ketogenic diet for weight management and medical purposes
      • 3.2.1.2 Rising awareness about ketone monitoring for diabetes management
      • 3.2.1.3 Advancements in blood ketone meter technology improving accuracy and convenience
      • 3.2.1.4 Increasing demand for homecare ketone monitoring solutions
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Variability in accuracy across different ketone meters
      • 3.2.2.2 Stringent regulatory approvals for new ketone monitoring devices
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Technological landscape
  • 3.6 Pricing analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Value chain analysis
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021-2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Blood glucose and ketone monitoring
  • 5.3 Blood ketone monitoring
  • 5.4 Consumables

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Diabetes management
  • 6.3 Weight and diet management
  • 6.4 Sports monitoring
  • 6.5 Epilepsy treatment
  • 6.6 Other application

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Brick and mortar
  • 7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 A. Menarini Diagnostics
  • 9.2 Abbott
  • 9.3 ACON
  • 9.4 eBmonitor
  • 9.5 EKF Diagnostics
  • 9.6 e-LinkCare
  • 9.7 Fora
  • 9.8 IN4 Care
  • 9.9 i-Sens
  • 9.10 KetoBM
  • 9.11 KETO-MOJO
  • 9.12 Ketoscan
  • 9.13 Lepu Medical
  • 9.14 TaiDoc
  • 9.15 VIVOO
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦